Editorial Policies

Focus and Scope

Journal of Pharmacopolium (JoP) covers various fields of study, such as;

1. Clinical Pharmacy.

2. Community Pharmacy.

3. Pharmaceutics.

4. Pharmaceutical Chemistry.

5. Pharmacogtion and Phytochemistry.

6. Other relevant fields.



Section Policies


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

The peer-review system in Journal of Pharmacopolium is through blind review. All manuscripts submitted to Journal of Pharmacopolium  (Journal of Pharmacopolium Practice) will be peer-reviewed at least one reviewer. The publication decision is made by the Editor based on Reviewers' recommendation and Editorial Board's consideration.


Publication Frequency

Jornal Of Pharmacopolium is published every 3 years April, August and Desember


Publication Ethics

This journal follows the guidelines of the Publication Ethics Committee (COPE) in dealing with all aspects of ethical publications and, in particular, how to handle research cases and publication violations. All articles in this journal that involve human subjects must respect the ethical principles of research as explained in the Helsinki Declaration and studies involving animals must comply with the International Guiding Principles for Biomedical Research developed by the International Medical Organizations Board (CIOMS).

The Journal of Pharmacopolium is adapting COPE to meet high-quality ethical standards for publishers, editors, writers, and reviewers. As an important issue, the ethics of publication need to be clearly explained to improve the quality of research throughout the world. In this section, we explain the standards for editors, writers, and reviewers. In addition, the publisher does not have the right to interfere with the integrity of the content and only supports publishing in a timely manner.

For Editor

  1. The editor must be responsible for each article published in the Journal of Pharmacopolium.
  2. The editor must help the writer follow the instructions for the writer.
  3. The editor can communicate with other editors or reviewers in making the final decision.
  4. An editor has to evaluate the manuscript objectively for publication, judging each on its quality without looking to nationality, ethnicity, political beliefs, race, religion, gender, seniority, or institutional affiliation of the authors. He/she should decline his/her assignment when there is a potential for conflict of interest.
  5. An editor needs to ensure the document sent to the reviewer does not contain the information of the author, vice versa.
  6. Editors’ decisions should be informed to authors accompanied by reviewers’ comments unless they contain offensive or libelous remarks.
  7. The editor should respect requests from authors that an individual should not review the submission if these are well-reasoned and practicable.
  8. Editors and all staff should guarantee the confidentiality of the submitted manuscript.
  9. An editor will be guided by COPE flowcharts if there is a suspected misconduct or disputed authorship.

For Reviewer

  1. A reviewer needs to comment on ethical questions and possible research and publication misconduct.
  2. A reviewer will do the work in a timely manner and should notify the editor if they can not complete the work.
  3. A reviewer needs to keep the confidentiality of the manuscript.
  4. The reviewer should not accept to review the manuscripts in which there is a potential conflict of interest between them and any of the authors.

For Author

  1. The author affirms that the material has not been previously published and that they have not trans­ferred elsewhere any rights to the article.
  2. An author should ensure the originality of the work and they have properly cited others’ work in accordance with the format of the references.
  3. An author should not engage in plagiarism nor self-plagiarism.
  4. ‘Salami’ publication is strictly prohibited in Journal of Pharmacopolium.
  5. The author must ensure that they follow the authorship criteria described in the instructions for the authors of the Journal of Pharmacopolium.
  6. The author does not suggest any personal information that can make a patient's identity identifiable in all forms of description, photo, or genealogy sections. When photos of patients are very important and very necessary as scientific information, the author has received written approval and stated them clearly.
  7. In terms of experimenting on humans, the authors have stated that the research process is in accordance with the ethical standards of the Helsinki declaration, the domestic and foreign committees that lead human experiments. If there is doubt whether the research has proceeded in accordance with the declaration, the author must explain it. In the case of animal experiments, the authors have stated that the authors have followed domestic and foreign guidelines related to animal experiments in the laboratory.
  8. The author must provide the data editor and job details if there is a suspicion of data forgery or fabrication.
  9. Journal writers must clarify anything that might cause a conflict of interest such as employment, research costs, consultant fees, and intellectual property on the document disclosure form Journal of Pharmacopolium


Screening for Plagiarism

Manuscripts submitted to Journal of Pharmacopolium (Journal of Pharmacopolium Practice) are to be screened for plagiarism using Turnitin. Journal of Pharmacopolium (Journal of Pharmacopolium Practice) will promptly reject manuscripts that are leading to either self-plagiarism or plagiarism. Authors indicated performing plagiarism or self-plagiarism will be blacklisted and disallowed to submit their manuscripts to Journal of Pharmacopolium (Journal of Pharmacopolium Practice) . Please refer to our Author Guideline and Publication Ethics regarding our provisions of submission.